ADVB Financials Advanced Biomed Inc.
3 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2026 | $127637 | $7M | 0.0% | -4883.8% | 54.4% | 48.6% | — | — | $385535 |
| 2025 | — | -$3M | — | — | -93.7% | -14.3% | -$6M | — | $31139 |
| 2024 | — | -$3M | — | — | -167.3% | -62.4% | -$2M | — | $3M |
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | — | $694999 | — | — | 5.7% | 5.1% | — | — | $385535 |
| Mar '26 | — | -$488942 | — | — | -5.3% | -4.6% | -$241039 | — | $3M |
| Dec '25 | — | $7M | — | — | 72.3% | 63.2% | -$526464 | — | $3M |
| Sep '25 | — | -$386901 | — | — | -12.9% | -6.2% | -$612113 | — | $3M |
| Jun '25 | — | -$701611 | — | — | -20.2% | -3.1% | -$2M | — | $31139 |
| Mar '25 | — | -$1M | — | — | -33.5% | -16.7% | -$3M | — | $3M |
| Dec '24 | — | -$907904 | — | — | -146.7% | -20.2% | -$831149 | — | $3M |
| Sep '24 | — | -$265580 | — | — | -24.3% | — | -$49658 | — | $3M |
| Jun '24 | — | -$809386 | — | — | -48.7% | -18.1% | -$529084 | — | $3M |
| Mar '24 | — | -$1M | — | — | 212.2% | — | -$1M | — | $3M |
| Dec '23 | — | -$145345 | — | — | -73.8% | — | — | — | $3M |
Valuation over time
How the market has priced ADVB against its own fundamentals since 2025-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-earnings ratio has risen from 1.1× (Jun '26) to 1.5× (Sep '26).
- The price-to-sales ratio has fallen from 57.5× (Jun '26) to 26.4× (Nov '26).
Frequently asked questions
Is ADVB growing its revenue and profit?
See the revenue and net-income charts above for Advanced Biomed Inc.'s multi-year trend.
How much debt does ADVB have?
As of FY2026, Advanced Biomed Inc. reported — of total debt against $385535 of cash.
What is ADVB's profit margin?
In FY2026, gross margin was —, operating margin -4883.8%, and net margin 5231.3%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.